1. Home
  2. RYTM vs FND Comparison

RYTM vs FND Comparison

Compare RYTM & FND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rhythm Pharmaceuticals Inc.

RYTM

Rhythm Pharmaceuticals Inc.

HOLD

Current Price

$82.62

Market Cap

5.8B

Sector

Health Care

ML Signal

HOLD

Logo Floor & Decor Holdings Inc.

FND

Floor & Decor Holdings Inc.

HOLD

Current Price

$50.42

Market Cap

5.3B

ML Signal

HOLD

Company Overview

Basic Information
Metric
RYTM
FND
Founded
2008
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
RETAIL: Building Materials
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
5.8B
5.3B
IPO Year
2017
2014

Fundamental Metrics

Financial Performance
Metric
RYTM
FND
Price
$82.62
$50.42
Analyst Decision
Strong Buy
Buy
Analyst Count
14
16
Target Price
$131.14
$73.44
AVG Volume (30 Days)
505.0K
2.7M
Earning Date
05-05-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
28.34
1.05
EPS
N/A
0.37
Revenue
N/A
$4,684,088,000.00
Revenue This Year
$55.34
$7.53
Revenue Next Year
$86.06
$7.68
P/E Ratio
N/A
$25.11
Revenue Growth
N/A
5.12
52 Week Low
$55.31
$46.47
52 Week High
$122.20
$92.41

Technical Indicators

Market Signals
Indicator
RYTM
FND
Relative Strength Index (RSI) 39.88 45.40
Support Level $74.50 $46.47
Resistance Level $90.79 $55.38
Average True Range (ATR) 3.24 2.70
MACD -0.28 0.03
Stochastic Oscillator 23.60 39.37

Price Performance

Historical Comparison
RYTM
FND

About RYTM Rhythm Pharmaceuticals Inc.

Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company engaged in the development and commercialization of therapies for patients with rare neuroendocrine diseases. The company is focused on advancing its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. In addition, it has two early-stage investigational MC4R agonists in clinical development, RM-718 and bivamelagon, designed not to cause hyperpigmentation. The company is also focused on advancing potential candidates for congenital hyperinsulinism. It currently operates in two business segments: the United States, which generates maximum revenue, and International.

About FND Floor & Decor Holdings Inc.

Floor & Decor Holdings Inc operates as a specialty retailer in the hard surface flooring market. Its stores offer a range of tile, wood, laminate, and natural stone flooring products, as well as decorative and installation accessories at everyday low prices. It appeals to a variety of customers including professional installers, commercial businesses, Do It Yourself (DIY) customers, and customers who buy the products for professional installation. Geographically, the group has a presence in the United States region and also offers its product through an e-commerce site. The company segments include retail segment and others.

Share on Social Networks: